{"accession":"0001551152-26-000026","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001551152-26-000026/NetCashProvidedByUsedInOperatingActivities","change":0.07027106658809665,"cik":1551152,"company":"AbbVie Inc.","concept":{"label":"Operating cash flow","label_en":"Operating cash flow","label_ko":"\uc601\uc5c5\ud65c\ub3d9 \ud604\uae08\ud750\ub984","period_type":"duration","xbrl_tag":"NetCashProvidedByUsedInOperatingActivities"},"filed_at":"2026-08-03","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/0001551152-26-000026-index.htm","filing_url":"https://aiswingx.com/f/0001551152-26-000026","form":"10-Q","id":"0001551152-26-000026/NetCashProvidedByUsedInOperatingActivities","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/abbv-20260630.htm#f-509","unit":"USD","value":7265000000.0,"xbrl_fact_id":"f-509"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/abbv-20260630.htm#f-510","unit":"USD","value":6788000000.0,"xbrl_fact_id":"f-510"}],"statement":"AbbVie Inc. (ABBV) reported Operating cash flow of USD 7,265,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0001551152-26-000026, filed 2026-08-03).","ticker":"ABBV","url":"https://aiswingx.com/n/0001551152-26-000026/NetCashProvidedByUsedInOperatingActivities","verify_url":"https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/abbv-20260630.htm#f-509"}